SCHEMBL24112202

SCHEMBL24112202

CN1CCC2(CCCCN2C(=O)OC(C)(C)C)C1=O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GRIN2B Q13224 1/20 0.53
▸ GRIN2C Q14957 1/20 0.53
▸ JAK3 P52333 2/20 0.37
▸ CDK4 P11802 1/20 0.35
▸ SPR P35270 3/20 0.34
▸ HPGD P15428 1/20 0.34
▸ BUB1 O43683 1/20 0.33
▸ EPHX1 P07099 1/20 0.33
▸ CTSK P43235 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MAP3K14 Q99558 1/20 0.32
▸ PREP P48147 1/20 0.32
▸ USP30 Q70CQ3 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CCR5 P51681 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24112192 0.96 GRIN2B (0.57) GRIN2BGRIN2CJAK3CDK4SPR
SCHEMBL31341770 0.90 GRIN2B (0.54) GRIN2BGRIN2CJAK3CDK4HPGD
SCHEMBL21466075 0.84 GRIN2B (0.63) GRIN2BGRIN2CJAK3CDK4SPR
SCHEMBL24740823 0.83 GRIN2B (0.58) GRIN2BGRIN2CJAK3CDK4SPR
SCHEMBL21225326 0.79 GRIN2B (0.52) GRIN2BGRIN2CJAK3CDK4SPR
SCHEMBL24338392 0.79 GRIN2B (0.78) GRIN2BGRIN2CJAK3CDK4
SCHEMBL25852386 0.78 GRIN2B (0.51) GRIN2BGRIN2CJAK3CDK4BUB1
SCHEMBL23835781 0.78 GRIN2B (0.63) GRIN2BGRIN2CJAK3CDK4SPR
SCHEMBL30832396 0.78 GRIN2B (0.50) GRIN2BGRIN2CJAK3CDK4SPR
SCHEMBL22975107 0.77 GRIN2B (0.46) GRIN2BGRIN2CJAK3SPRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021252644-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2021-12-16 — — WO disclosed
Send feedback